Kangbingdu Oral Liquid for Influenza A: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10000828

Enrollment

Unknown

Registered

2010-03-18

Start date

2010-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza A

Interventions

Group A:placebo

Group B:Kangbingdu Oral Liquid

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged >=18 years old; 2. Patients diagnosed as mild influenza A including suspected cases, clinical diagnosis and confirmed by virology cases according to the criteria of WHO. Voluntarily participate this trial and sign the Inform consent; 3. Disease course was within 48 hours; 4. Temperature >=37.5 degree C; 5. WBC<12*10^9/L.

Exclusion criteria

Exclusion criteria: 1. Severe and critically disease, multiple organ failure have emerged; 2. Patients with psychiatric disease; 3. Patients received influenza A vaccines; 4. Patients with complications or pregnancy.

Design outcomes

Primary

Measure	Time frame
Time to alleviation of symptoms;Incidence of complication;	—

Secondary

Measure	Time frame
Treatment expense;incidence of developing to severe influenza;Negative rate of influenza virus detection;Time to fever clearance;	—

Countries

China

Contacts

Public ContactChuanjian Lu

luchuanjian888@vip.sina.com+86 20 81887233-31223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026